Biotech

All Articles

Editas profit Vertex Cas9 licensing civil rights for $57M

.Against the scenery of a Cas9 license fight that refuses to die, Editas Medicine is moneying in a c...

Ultragenyx changes genetics treatment dosing to dial up efficacy

.A minority of individuals taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have actua...

Biopharma cutback cost stabilizes in Q3: Brutal Biotech study

.As summer heat energy looks to cool winds, really hopes that this year would carry widespread marke...

J &amp J drops stage 2 dengue candidate in most up-to-date shift from vaccines

.Johnson &amp Johnson's deprioritization of its own transmittable disease pipeline has actually stat...

Relay drops 10% of workers after earlier unemployments in July

.Preciseness medication biotech Relay Therapies is actually dropping approximately 10% of its staff ...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has actually produced virtually twenty thousand europeans ($ 22 million) coming from a...

Lundbeck water faucets Charles Stream for AI-enabled neuro medicine finding

.Lundbeck has tapped Charles Stream Laboratories' expert system functionalities to assist the findin...

Big pharma, biotech 'will not essentially be cooperative' in artificial intelligence: S&ampP

.Big Pharma is investing intensely in artificial intelligence to reduce advancement timelines and al...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Biography has roped in $115 million in series B funds to progress preclinical antibody syst...

IGM rotates from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2013 giving up workers as well as simplifying its own cancer cells pipelin...